Behavioral
Community Medical Associates, INC.
Community Medical Associates, INC. was paid $48.97M by Medicaid between Jan 2018 and Dec 2024, across 46 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 36% of everything it billed.
33Billing provider infoCOMMUNITY MEDICAL ASSOCIATES, INC.
LOUISVILLE, KY 40241
LOUISVILLE, KY 40241
33aNPI1306983762assigned 02/01/2007
33bProvider typeClinical Neuropsychologist
28Total paid$48.97M
24GClaims894,867
24DCodes billed46
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Neuropsychologist providers in Kentucky
Rank by total paid#2 of 8
Median peer was paid$49K
This provider vs. median990×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official GAST, SHELLEY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74,047 | $3.42M | |
| 2019 | 79,448 | $4.14M | |
| 2020 | 74,098 | $3.80M | |
| 2021 | 139,175 | $8.01M | |
| 2022 | 177,964 | $10.81M | |
| 2023 | 194,886 | $10.43M | |
| 2024incomplete | 155,249 | $8.37M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 36% | 162,108 | 151,854 | $17.61M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 252,864 | 238,258 | $15.39M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 223,951 | 212,086 | $9.66M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.5% | 125,280 | 118,913 | $3.17M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 25,483 | 23,700 | $1.68M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 12,991 | 12,292 | $430K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 3,797 | 3,453 | $319K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 5,311 | 5,125 | $221K |
| 87631 | <1% | 836 | 790 | $78K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 966 | 944 | $67K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,231 | 7,944 | $56K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,419 | 1,351 | $53K |
34 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 641 | $47K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,738 | $46K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,115 | $34K |
| 81003 | <1% | 39,742 | $34K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,113 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,362 | $16K |
| 87807 | <1% | 1,171 | $13K | |
| 81025 | <1% | 2,494 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 260 | $5K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 14 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 938 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 399 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 410 | $382.20 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 12 | $356.80 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 423 | $265.56 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 148 | $261.07 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 87 | $174.93 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 115 | $169.60 |
| 86308 | <1% | 189 | $156.07 | |
| 82947 | <1% | 171 | $74.84 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 66 | $51.55 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 196 | $25.30 |
| 93000 | <1% | 138 | $22.27 | |
| 73610 | <1% | 239 | $17.43 | |
| 73630 | <1% | 235 | $17.43 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 22 | $16.96 |
| 81002 | <1% | 582 | $14.26 | |
| 36416 | <1% | 67 | $12.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 283 | $1.65 |
| 73562 | 0% | 57 | $0.00 | |
| 73130 | 0% | 75 | $0.00 | |
| 73140 | 0% | 47 | $0.00 | |
| 73110 | 0% | 67 | $0.00 | |
| 69209 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAST, SHELLEY (VP MANAGED CARE)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.